Abstract:The process of identifying novel human immunodeficiency virus 1 (HIV-1) inhibitors presents a challenge for industrial and scientific research. Virus-cell-based screening approaches offer some advantages in the quest for novel inhibitors because they include multiple targets in a single screen and in some cases reveal targets not captured in biochemical assays. In this study, a high-throughput screening (HTS) system for HIV-1 inhibitors was developed, which allows the simultaneous screening of all the HIV-1 targets required for replication in the cell culture. HeLa/cluster of differentiation 4 (CD4)/long terminal repeat (LTR) indicator cells, which stably expressed high levels of HIV receptor CD4 and contained the firefly luciferase reporter gene under the control of the HIV-1 LTR promoter, were generated. The expression of CD4 and LTR function in this cell line was validated by Western blot and luciferase assay. MT2 cells, a human T-cell leukemia cell line that support high levels of HIV-1 replication, were infected with HIV-1, and then the infected MT2 cells were co-cultured with HeLa/CD4/LTR cells. In the optimized assay conditions, HIV-1 replication occurs rapidly in the MT2 cells, resulting in the infection of the HeLa/CD4/LTR cells and a significant induction of luciferase signals through LTR, which is activated by the expression of HIV-1 tat gene. The luciferase signals of HeLa/CD4/LTR cells co-cultured with HIV-1 infected MT2 cells were significantly stronger than the signals of noninfected HeLa/CD4/LTR cells (P < 0.001). The inhibitory effects of HIV-1 inhibitors (3′-Azido-3′-deoxythymidine [AZT], efavirenz [EFV], and nevirapine [NVP]) were evaluated with this assay, and the inhibitory concentration 50% (IC50) values of the above three inhibitors were 58, 1.4, and 85 nmol/L, respectively, indicating that the assay provides the necessary sensitivity for identifying antiviral molecules. The Z′ factor had a value of 0.563, indicating this is a very robust assay. These results suggested that HIV-1 infection assay represents a novel approach to HIV-1 antiviral screening that allows for the effective execution of HTS campaigns.

[A Non-Infectious and Quantitative Cell-Based Bioassay for Screening HIV Entry Inhibitors Targeting HIV Envelope Proteins].

A Non-Infectious Assay for Detecting HIV Env-induced Cell-Cell Fusion

A Convenient Cell Fusion Assay for Rapid Screening for Hiv Entry Inhibitors

Rapid and Automated Fluorescence-Linked Immunosorbent Assay for High-Throughput Screening of Hiv-1 Fusion Inhibitors Targeting Gp41

Development of a Cell-Based Enzyme-Linked Immunosorbent Assay for High-Throughput Screening of HIV Type 1 Entry Inhibitors Targeting the Coreceptor CXCR4.

A Sensitive Hiv-1 Envelope Induced Fusion Assay Identifies Fusion Enhancement of Thrombin

Establishment of a New Screening Method for Anti-Hiv-1 Drugs

Automatic quantitation of HIV-1 mediated cell-to-cell fusion with a digital image analysis system (DIAS): application for rapid screening of HIV-1 fusion inhibitors.

Establishment of a High-Throughput Screening System for Universal Anti-Hiv Targets

A Screening Assay for Antiviral Compounds Targeted to the HIV-1 Gp41 Core Structure Using a Conformation-Specific Monoclonal Antibody

High-throughput Screening Using Pseudotyped Lentiviral Particles: a Strategy for the Identification of HIV-1 Inhibitors in a Cell-Based Assay.

Assessment of the susceptibility of mutant HIV-1 to antiviral agents.

Liquid Crystal Based Binding Assay for Detecting HIV-1 Surface Glycoprotein

Screening HIV-1 Fusion Inhibitors Based on Capillary Electrophoresis Head-End Microreactor Targeting to the Core Structure of Gp41

Short Communication: in VitroSynergy Between Peptides or Neutralizing Antibodies Targeting the N- and C-Terminal Heptad Repeats of HIV Type 1 Gp41

Antibodies to Several Conformation-Dependent Epitopes of Gp120/gp41 Inhibit CCR-5-dependent Cell-to-cell Fusion Mediated by the Native Envelope Glycoprotein of a Primary Macrophage-Tropic HIV-1 Isolate

A Convenient Cell Fusion Assay for the Study of SARS-CoV Entry and Inhibition.

Quantifying the Sensitivity of HIV-1 Viral Entry to Receptor and Coreceptor Expression

[Virtual Screening of Small Molecular HIV-1 Entry Inhibitor NC-2 Targeting Gp120 and Its Action Mechanism].

High Throughput Screening and Characterization of HIV-1 Entry Inhibitors Targeting Gp41: Theories and Techniques.

An Indicator Cell Assay for T-Cell Tropic, Macrophage-Tropic, and Primary Isolates of HIV-1 Based on Green Fluorescent Protein